IM8, the wellness brand co-founded by David Beckham and owned by Nasdaq-listed Prenetics, has lined up a hefty $1 billion non-dilutive growth financing commitment from General Catalyst’s Customer Value Fund. The money is earmarked to turn up the volume on marketing, ambassador deals and new products, while Prenetics says it will fuel customer acquisition without putting more strain on shareholder equity limits. After what it called a record June, the company also bumped up IM8’s 2026 revenue outlook and says the brand is now shipping around 200,000 servings a day across 43 countries.
How This Billion-Dollar Setup Actually Works
According to a press release from Prenetics, the $1 billion commitment is structured to cover up to 70% of IM8’s monthly marketing spend on a cohort basis. General Catalyst’s return is capped and is tied only to the revenue those financed customer cohorts generate, and no equity is issued as part of the deal. Prenetics says that setup lets IM8 lean harder into digital performance campaigns, TV, sponsorships and ambassador partnerships while keeping the balance sheet relatively nimble.
“Every dollar we have ever spent acquiring customers has already returned $1.44 in gross profit,” Prenetics CEO Danny Yeung said in the release, a statistic that helps explain why the company is comfortable taking on a large, marketing-focused facility.
The Scale Behind The Bet
Per the company’s Form 6-K filed with the SEC (via StreetInsider) and reporting by CityBiz, IM8 logged approximately $17 million in preliminary, unaudited revenue in June. Since launch, the brand says it has delivered more than 50 million servings to customers and hit $100 million in annualized run-rate revenue in roughly 11 months.
IM8 also told investors it averages an order every 27 seconds and ships around 200,000 servings daily across 43 countries. Those growth and engagement metrics were part of what General Catalyst underwrote in its diligence before offering up the billion-dollar commitment.
Why General Catalyst Is All In
General Catalyst’s Customer Value Fund is designed to bankroll sales and marketing for subscription-style businesses and then get repaid directly from the revenue those financed cohorts bring in, rather than by taking equity stakes, according to General Catalyst. Prenetics told investors that General Catalyst vetted IM8’s cohort retention and unit economics before signing off on the facility.
In the company announcement from Prenetics, General Catalyst’s lead on the deal described IM8 as a fast-scaling, category-defining consumer health brand, signaling that the firm sees the wellness line as more than just a celebrity-backed side project.
What Comes Next For IM8 And Prenetics
Looking ahead, Prenetics says IM8 plans to expand its lineup with IM8 Hydration slated for Q4 2026 and a premium gummies line targeted for Q1 2027, while at the same time ramping up ambassador partnerships and retention marketing, per CityBiz. On the accounting side, shareholders will want to watch how the Customer Value Fund arrangement shows up in Prenetics’ numbers.
The company will record the financing as a financial liability, and the return component will be recognized below operating income, as disclosed in its Form 6-K via StreetInsider.
For now, the billion-dollar firepower gives IM8 room to chase more customers and subscriptions without handing over additional equity. Whether the company can keep those cohort economics humming as it pushes into new product categories and more countries is the test that Prenetics and General Catalyst will be watching closely.
.jpg){kind=link}